发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 559 |
| England | 297 |
| France | 236 |
| Italy | 222 |
| GERMANY (FED REP GER) | 167 |
| Canada | 159 |
| Australia | 150 |
| Spain | 129 |
| Netherlands | 128 |
| Belgium | 109 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| HARVARD UNIVERSITY | 146 |
| UNICANCER | 135 |
| UNIVERSITY OF LONDON | 124 |
| UNIVERSITY OF TEXAS SYSTEM | 112 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 90 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 86 |
| UNIVERSITY OF TORONTO | 80 |
| DANA-FARBER CANCER INSTITUTE | 78 |
| ROYAL MARSDEN NHS FOUNDATION TRUST | 68 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC... | 62 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Pembrolizumab in patients with advanced hepatocellular c... | 313 |
| Nivolumab plus ipilimumab or nivolumab alone versus ipil... | 272 |
| Long-term safety and activity of axicabtagene ciloleucel... | 263 |
| Ramucirumab after sorafenib in patients with advanced he... | 232 |
| Tumour-infiltrating lymphocytes and prognosis in differe... | 218 |
| Atezolizumab in combination with carboplatin plus nab-pa... | 169 |
| Combination nivolumab and ipilimumab or nivolumab alone ... | 155 |
| Pembrolizumab versus ipilimumab in advanced melanoma (KE... | 146 |
| [Lu-177]-PSMA-617 radionuclide treatment in patients wit... | 143 |
| Use of prostate systematic and targeted biopsy on the ba... | 140 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| CANCERS | 997 |
| LANCET ONCOL | 762 |
| FRONT ONCOL | 753 |
| BMC CANCER | 563 |
| CLIN CANCER RES | 524 |
| J CLIN ONCOL | 501 |
| SCI REP-UK | 466 |
| FUTURE ONCOL | 438 |
| INT J MOL SCI | 438 |
| ANN ONCOL | 434 |